Commentary on “Asymmetric Dimethylarginine as a Potential Biomarker for Cardiovascular Risk Assessment in Long-Standing Type 1 Diabetes Mellitus”
Asymmetric dimethylarginine (ADMA) has been discussed as a potential biomarker of cardiovascular risk, but its interpretation in type 1 diabetes mellitus (T1DM) remains context-dependent. In commenting on the recent study by Chausheva et al., we suggest that the findings should be interpreted cautio...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ivano-Frankivsk National Medical University
2026-04-01
|
| סדרה: | Galician Medical Journal |
| נושאים: | |
| גישה מקוונת: | https://ifnmujournal.com/gmj/article/view/2403 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|